Impact of epigenetic reprogramming on antitumor immune responses in glioma
Epigenetic remodeling is a molecular hallmark of gliomas, and it has been identified as a key mediator of glioma progression. Epigenetic dysregulation contributes to gliomagenesis, tumor progression, and responses to immunotherapies, as well as determining clinical features. This epigenetic remodeli...
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | 論文 |
| 言語: | English |
| 出版事項: |
American Society for Clinical Investigation
2023-01-01
|
| シリーズ: | The Journal of Clinical Investigation |
| オンライン･アクセス: | https://doi.org/10.1172/JCI163450 |